Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $36.65 USD
Change Today 0.00 / 0.00%
Volume 0.0
STDAF On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
Xetra
As of 8:10 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Helmut Kraft

Chief Financial Officer and Member of Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 4 different industries.

See Board Relationships
55€2,750,000
As of Fiscal Year 2014

Background*

Mr. Helmut Kraft has been the Chief Financial Officer and Member of Executive Board at Stada-Arzneimittel AG since January 1, 2010. A trained attorney, Mr. Kraft served as Head of Group Finance, Taxes and Investments at the PHOENIX group, a leading European pharmaceutical wholesaler, since 1996. He served at Landis & Gyr Holding GmbH (Siemens Building Technologies) as Head of Finance and Taxes from 1996 to 2009 and at KPMG Deutsche Treuhand-Gesellschaft, Aktiengesellschaft, ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1987
University of Heidelberg

Other Affiliations*

Annual Compensation*

Salary€750,000
Bonus€399,000
Total Annual Compensation€1,149,000

Stock Options*

Long Term Incentive Plan€1,575,000
All Other Compensation€26,000

Total Compensation*

Total Annual Cash Compensation€1,175,000
Total Short Term Compensation€1,149,000
Other Long Term Compensation€26,000
Total Calculated Compensation€2,750,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STDAF:US $36.65 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.